Wellcome Trust Sanger Institure – Genome Research Limited

![]() | Wellcome Trust Sanger Institute, Genome Research LimitedGenome Research Limited CB10 1SA HINXTON United Kingdom |

Wellcome Trust Sanger Institute, Genome Research LimitedGenome Research LimitedCB10 1SAHINXTONUnited Kingdomwww.sanger.ac.uk

principal investigatorTel.: +44 122 349 47 57Tel.2: +44 122 349 47 39

Michael Stratton (MD, PhD) is Director of the Wellcome Trust Sanger Institute. He was leader of the group that mapped and identified the high risk breast cancer susceptibility gene, BRCA2. His research interests are in the genetics of cancer.